<DOC>
	<DOCNO>NCT01784016</DOCNO>
	<brief_summary>This trial aim determine whether dopamine D3 receptor elevate smoker versus nonsmoker whether correlation exist D3 receptor bind potential ( BP ) functional MRI ( fMRI ) reactivity smoke cue , associate smoking relapse vulnerability . Neuroimaging measure D3 BP smoke cue fMRI reactivity collect concurrently otherwise healthy nicotine-dependent smoker age-matched nonsmoker use 3 Tesla MRI scanner configure conduct fMRI Positron Emission Tomography ( PET ) . We measure D3 receptor BP use radiolabeled [ 11C ] - ( + ) -PHNO , relatively high affinity D3 versus D2 receptor . We hypothesize D3 BP elevate smoker versus nonsmoker smoker , positive correlation smoking cue fMRI reactivity D3 BP .</brief_summary>
	<brief_title>Concurrent PET D2/D3 Receptor Imaging fMRI Smoking Cue Reactivity Smokers</brief_title>
	<detailed_description />
	<mesh_term>Tobacco Use Disorder</mesh_term>
	<criteria>competent provide write informed consent Smokers : selfreport smoke 15 cigarettes/day past year , selfreport smoking first cigarette day within 30 minute awaken , meet DSMIV criterion Nicotine Dependence , provide expired breath carbon monoxide read &gt; 10 ppm enrollment Nonsmokers : selfreport consume &lt; 100 cigarette lifetime , none last 6 month , provide expired breath carbon monoxide read &lt; 9 ppm enrollment Women childbearing potential : negative STAT serum betahuman chorionic gonadotrophin pregnancy test scan pregnant able become pregnant willing undergo blood pregnancy test unstable medical illness likely hospitalization treatment within 6 month lifethreatening arrhythmia , cerebrovascular cardiovascular event within 6 month enrollment ; liver function test elevate 2.5x normal ; CNS tumor seizure disorder user tobacco nicotinecontaining product ( gum , patch , ecigarettes ) lifetime history DSMIV bulimia , organic mental disorder , brain injury psychotic disorder 6 month history nonnicotine substance use disorder major depression history multiple adverse drug reaction current use exclude concomitant medication ( smoke cessation medication ) know history allergic reaction PET ligand [ 11C ] PHNO , component , medication</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>May 2014</verification_date>
</DOC>